THEA HEATON: Open Payments
NPI 1811998628 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,114 in 49 payments from 12 companies in 2025. Trend: 2023 $1,020 · 2024 $2,480 · 2025 $1,114
Food & beverage: $893Education: $222
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $319 |
| Janssen Biotech, Inc. | 7 | $243 |
| UCB, Inc. | 9 | $167 |
| Galderma Laboratories, L.P. | 4 | $86 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| Incyte Corporation | 2 | $40 |
| Amgen Inc. | 2 | $38 |
| GENZYME CORPORATION | 1 | $34 |
| Organon LLC | 3 | $26 |
Products named: TREMFYA, SKYRIZI, Bimzelx, RINVOQ, OPZELURA, OTEZLA, DUPIXENT, NEMLUVIO.
Industry payments across ID — which companies pay providers there.
